Next Article in Journal
Measuring Appropriate Antibiotic Prescribing in Acute Hospitals: Development of a National Audit Tool Through a Delphi Consensus
Next Article in Special Issue
The Continuing Threat of Methicillin-Resistant Staphylococcus aureus
Previous Article in Journal
Penicillin G Sodium as a Treatment of Otosyphilis with Hearing Loss
Previous Article in Special Issue
Prevalence of Methicillin-Resistant Staphylococcus sp. (MRS) in Different Companion Animals and Determination of Risk Factors for Colonization with MRS
Open AccessArticle

Identification of Small Molecule Inhibitors of Staphylococcus aureus RnpA

Department of Microbiology and Immunology, University of Rochester School of Medicine, Rochester, NY 14642, USA
Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN 47906, USA
Purdue Institute of Inflammation, Immunology and Infectious Disease, Purdue University, West Lafayette, IN 47906, USA
Purdue Institute for Drug Discovery, Purdue University, West Lafayette, IN 47906, USA
Author to whom correspondence should be addressed.
Antibiotics 2019, 8(2), 48;
Received: 1 April 2019 / Revised: 23 April 2019 / Accepted: 25 April 2019 / Published: 28 April 2019
(This article belongs to the Special Issue Staphylococci Antimicrobial Resistance)
Staphylococcus aureus RnpA is thought to be a unique dual functional antimicrobial target that is required for two essential cellular processes, precursor tRNA processing and messenger RNA degradation. Herein, we used a previously described whole cell-based mupirocin synergy assay to screen members of a 53,000 compound small molecule diversity library and simultaneously enrich for agents with cellular RnpA inhibitory activity. A medicinal chemistry-based campaign was launched to generate a preliminary structure activity relationship and guide early optimization of two novel chemical classes of RnpA inhibitors identified, phenylcarbamoyl cyclic thiophene and piperidinecarboxamide. Representatives of each chemical class displayed potent anti-staphylococcal activity, limited the protein’s in vitro ptRNA processing and mRNA degradation activities, and exhibited favorable therapeutic indexes. The most potent piperidinecarboxamide RnpA inhibitor, JC2, displayed inhibition of cellular RnpA mRNA turnover, RnpA-depletion strain hypersusceptibility, and exhibited antimicrobial efficacy in a wax worm model of S. aureus infection. Taken together, these results establish that the whole cell screening assay used is amenable to identifying small molecule RnpA inhibitors within large chemical libraries and that the chemical classes identified here may represent progenitors of new classes of antimicrobials that target RnpA. View Full-Text
Keywords: Staphylococcus aureus; RnpA; mRNA degradation; tRNA processing; mupirocin Staphylococcus aureus; RnpA; mRNA degradation; tRNA processing; mupirocin
Show Figures

Figure 1

MDPI and ACS Style

Colquhoun, J.M.; Ha, L.; Beckley, A.; Meyers, B.; Flaherty, D.P.; Dunman, P.M. Identification of Small Molecule Inhibitors of Staphylococcus aureus RnpA. Antibiotics 2019, 8, 48.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop